9999999997-11-015754.txt : 20110922
9999999997-11-015754.hdr.sgml : 20110922
20110922122608
ACCESSION NUMBER: 9999999997-11-015754
CONFORMED SUBMISSION TYPE: CT ORDER
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20110922
DATE AS OF CHANGE: 20110922
20110922
20110922
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: ELITE PHARMACEUTICALS INC /DE/
CENTRAL INDEX KEY: 0001053369
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 223542636
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0331
FILING VALUES:
FORM TYPE: CT ORDER
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-15697
FILM NUMBER: 111102674
BUSINESS ADDRESS:
STREET 1: 165 LUDLOW AVENUE
CITY: NORTHVALE
STATE: NJ
ZIP: 07647
BUSINESS PHONE: 2017502646
MAIL ADDRESS:
STREET 1: 165 LUDLOW AVENUE
CITY: NORTHVALE
STATE: NJ
ZIP: 07647
CT ORDER
1
filename1.pdf
begin 644 filename1.pdf
M)5!$1BTQ+C4-)>+CS],-"C$P(#`@;V)J#3P\+TQI;F5A7!E+UA2968O5ULQ(#(@,5T^/G-T#0IE;F1S
M=')E86T-96YD;V)J#7-T87)T>')E9@T*,`T*)25%3T8-"B`@("`@("`@#0HR
M,B`P(&]B:@T\/"]&:6QT97(O1FQA=&5$96-O9&4O22`X-"],(#8X+TQE;F=T
M:"`V,2]3(#,X/CYS=')E86T-"FC>8F!@8&9@8.)G``+V%PRH@!&(61@X&I#%
MF*&8@:&1@9N!_9D93*5(%%1'&U@7@_(9")^1'2#``-E`!3@-"F5N9'-T7!E+T-A=&%L;V<^/@UE;F1O8FH-,3(@
M,"!O8FH-/#PO0V]N=&5N=',@,30@,"!2+T-R;W!";WA;,"`P(#8Q,B`W.3)=
M+TUE9&EA0F]X6S`@,"`V,3(@-SDR72]087)E;G0@."`P(%(O4F5S;W5R8V5S
M(#$V(#`@4B]2;W1A=&4@,"]4>7!E+U!A9V4^/@UE;F1O8FH-,3,@,"!O8FH-
M/#PO1FEL=&5R+T9L871E1&5C;V1E+T9II%+;;AHQ$/V5>6P?J"][\2)%2)"$
MM%))47:55$(\N.#"2GM!NXY*_KXS]@(;U+0JD>6U/>?8`RA$!)D!Q4$H(4(+@0<'7%;O?V+K7:&MS?I8)N<7@8C=BTKBS&LDS298SA
MUMWT\+RI5ZFQ"S:_F;+,[.UR-$+ZMSG\U$5K<#,#P=)Q=TQGP#]QR;*7G3GE
M9/7.X^[NN%V9RD(R%.Q:[SZ;?+.UJ)-S=F,\-)`B9M-";UH(0J=P,JGWBT$4
M)3`(N,+Z.!;.9;QTZ%27>?'R(?I8%(7
MZUGF\-0VQJZV[+YN2EVXT).7I%#1%ZN+?#6N-H4!SE)KRD?\S[&OC[@DNC:LV/YZG>=/:ZZUN()!G6:C1U*2O
MNF,(H5CZ_,.2H*QY-D[941X^O;;;=B$C#C0B[M?^("P(`O`<8OQM_ND-)67W
MI1G'"F)TG5*)FT$R="R*#\/0\S!.''\KBF*'^G?X<3V,4UYBAO@&[[X^(E7B
M*\$UP4HH=F![)FD(/+)\KPGCUR;DZC(3_M-_X1O^2^3[['>I\R0_X=N]]WG/-4Q8OO=N=M.@YQ#&?NK\@N>YCSN]^C$W\+,``O+HA_#0IE;F1S=')E86T-96YD;V)J#3$T(#`@
M;V)J#3P\+T9I;'1EX?<%XW@B!##,;L@)'6FFR6AF[";TR-N/+
M9O+W6WT+A)`,"+ML=Y^J.G6JS*>;-8/'=G"5#CZEJ0\,TNV`^>#A%T^)![$W
MIN,0TOW`@T?\I;D\/`T(..F_`S8&EU$607IM[J2_&\,-:)(IZ
MMH(;QQUC^JO),ETL;S#"Y5R%QGP:AE@3N]LWNR-?[UYHL7
MAC'<.(K.DO(M^=)C^F4&EC(D:V8H@LDTA;LYL"20%?!):`"Q&F'T?J;HSS]S
M%UH.I24=STK1`'BXMP1^W-1_^;''0K6>QB=:)/]<^JAUV`6A[@))G8D@/,K;>T/Z<>1=SM&DU_:;O2/+++J.%Y!5D!T.):[H1%U!7Q4HKY43TX#T#AXP,3_<
MN#XT_$?/VTY4CYHA;#792T>-FACRNMHBG0$1!:\ZD3D1^BJA:[@VN[V3X`F?
M@5Y7RX:(20.BLC<8'AN]3H^PVV6,?":E][DTJP;)$2U%=%K9]!O;4,:]@7AG&0G(<^R;LA
M1'!/UW1*(8K\![)YIS6S:%N-.A<
MR,`Y[##W@G<<9T3$1UK/WXU1QQ7]<^5A16=2&[,CY&=R;R[T2GB)YU,3LA^4H(
M=Z17`@?>B+IHH3WP7&JJ^&Q#4[CO#E'3$\H=#KLP,>\B`-NDX*CF8!Z-/;3#
M4/5P4_>/._-(=9]9-30&-N)(1Z#'96C$=1&7_1+7#]X#_F56IR3:3I\;%J?8
M9XI&T4J-#F636T$;T5I=)^R"=)A6X25A#U&43=MGE1*H_H>@4#Z<904JXS%3
MKX2^V]6-Z)X_?S#.WAKJA87K%-/X64O6&'9\K>FK]$G@*93]EDD#_]X10^^5
M//G'VXTR[$F!1*255XD<(W:JO7%WT'#.NYM'=,"%,=@@FXURY-W"^>
M^>GNR%>[32R*)TW(+!W\+\``+!2VO0T*96YDG)E4WI.5&-Z:V,Y9"(_/@H\>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS
M.FUE=&$O(B!X.GAM<'1K/2)!9&]B92!835`@0V]R92`T+C(N,2UC,#0S(#4R
M+C,W,C&UL;G,Z6YT87@M;G,C(CX*("`@("`@/')D9CI$97-C&UL;G,Z<&1F/2)H='1P.B\O;G,N861O
M8F4N8V]M+W!D9B\Q+C,O(CX*("`@("`@("`@/'!D9CI0&UP.D-R
M96%T941A=&4^,C`Q,2TP.2TR,E0Q,CHR,SHP-"TP-#HP,#PO>&UP.D-R96%T
M941A=&4^"B`@("`@(#PO&UP34TZ26YS=&%N8V5)1#YU=6ED.F)F,#%B
M8C=D+31B,V(M-#%E-"TX-#8Q+6,Y-C@Y9#0S.3$Y,3PO>&UP34TZ26YS=&%N
M8V5)1#X*("`@("`@/"]R9&8Z1&5S8W)I<'1I;VX^"B`@(#POJ'5!:D
MZ@?(RQ"H,P%`!_Y6TF@S&FVF(10>I:$%KJ
MXF)-BH'@*\\G_?UFZ-SMAKNK0$-=9^W."Y)8]I4=;3*[D)O8X]I-[$1W-CK/
M=65,;LQ!%ZDN$JV3GQ6S_C:3?W.I;`CPB(-80JF,,C*[HOT_Z0GM/CL2[4SX
MG!@ZO[$/P1%4JE!'&,7@5XN?;90RNWL.3EQ]=#=\,0Q(%E(P)YT7*K(C97&6
M3?,58`!?/D$Z#0IE;F1S=')E86T-96YD;V)J#34@,"!O8FH-/#PO1&5C;V1E
M4&%R;7,\/"]#;VQU;6YS(#0O4')E9&EC=&]R(#$R/CXO1FEL=&5R+T9L871E
M1&5C;V1E+TE$6SQ$13$V,C@U-S%%.35#1#!!-T$R0S0U1#(T,$8T.$(Y1#X\
M,48Y1D$T148P13$S-48T04(Y0T-&,#!%,$5"1D%%.#`^72]);F9O(#D@,"!2
M+TQE;F=T:"`T.2]2;V]T(#$Q(#`@4B]3:7IE(#$P+U1Y<&4O6%)E9B]76S$@
M,B`Q73X^')E
/9@T*,3$V#0HE)45/1@T*
`
end